Elisabeth Bumes

Reduced expression of CYLD in human colon and hepatocellular carcinomas

Claus Hellerbrand, Elisabeth Bumes, F Bataille et al. · Carcinogenesis · 2006 · 164 citations · Full text

Medicine, Molecular Biology, Oncology +17

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

Caroline Hertler, Jörg Felsberg, Dorothee Gramatzki et al. · European Journal of Cancer · 2023 · 73 citations · Full text

Medicine, Oncology, Cancer Genetics +15

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning

Elisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner et al. · Cancers · 2020 · 45 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey

Niklas Schäfer, Elisabeth Bumes, Fabian Eberle et al. · Journal of Neuro-Oncology · 2021 · 33 citations · Full text

Medicine, Oncology, Medical Oncology +10

Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre

Alexander Scheiter, Frederik Hierl, Florian Lüke et al. · British Journal of Cancer · 2022 · 30 citations · Full text

Medicine, Oncology, Pathology +13